Sarepta Therapeutics to Restructure, Lay Off 500 Workers The Wall Street Journal Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label Sarepta Therapeutics Sarepta Stock Soars 30%. Why Layoffs and a ‘Black-Box’ Warning Are Good News. Barron’s Sarepta Soars as Gene Therapy Stays on Market With Warning Bloomberg Sarepta Tags DMD Gene Therapy …
Read More »